3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Recruiting
2
Active not recruiting
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
11
Prostatic Neoplasms
9
Uterine Neoplasms
2
Hyperthermia
2
Endometrial Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Directly Observed Therapy
1
Cervical Adenocarcinoma
1
Carcinoma, Renal Cell
1
Adenocarcinoma
1
Interventions
pembrolizumab
25
Paclitaxel
20
Carboplatin
17
Bevacizumab
12
Specimen Handling
10
Letrozole
10
abemaciclib
7
dostarlimab
6
Taxes
6
Blood Specimen Collection
6
Medroxyprogesterone Acetate
5
Magnetic Resonance Spectroscopy
5
Fulvestrant
5
Drug Therapy
5
Doxorubicin
5
Cisplatin
5
Biopsy
5
olaparib
4
lenvatinib
4
atezolizumab
4
Radiotherapy
4
Progestins
4
Observation
4
Nivolumab
4
Megestrol Acetate
4
Immunoglobulin G
4
Gemcitabine
4
trastuzumab deruxtecan
3
palbociclib
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Endometrial Neoplasms
×
Brachytherapy
×
Clear all
NCT05857631
2025-04-15
PARCERII
Tata Memorial Centre
Phase NA
Recruiting
90 enrolled
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled